FR2312260B1 - - Google Patents
Info
- Publication number
- FR2312260B1 FR2312260B1 FR7615645A FR7615645A FR2312260B1 FR 2312260 B1 FR2312260 B1 FR 2312260B1 FR 7615645 A FR7615645 A FR 7615645A FR 7615645 A FR7615645 A FR 7615645A FR 2312260 B1 FR2312260 B1 FR 2312260B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH671975 | 1975-05-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2312260A1 FR2312260A1 (fr) | 1976-12-24 |
| FR2312260B1 true FR2312260B1 (enExample) | 1978-12-08 |
Family
ID=4313966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7615645A Granted FR2312260A1 (fr) | 1975-05-26 | 1976-05-24 | Preparations a base de calcitonine, a action prolongee |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS51144721A (enExample) |
| AU (1) | AU507537B2 (enExample) |
| BE (1) | BE842189A (enExample) |
| CA (1) | CA1098444A (enExample) |
| DE (1) | DE2623074A1 (enExample) |
| FR (1) | FR2312260A1 (enExample) |
| GB (1) | GB1548984A (enExample) |
| HK (1) | HK15982A (enExample) |
| IE (1) | IE43770B1 (enExample) |
| IL (1) | IL49653A (enExample) |
| MY (1) | MY8200284A (enExample) |
| NL (1) | NL7605559A (enExample) |
| NZ (1) | NZ180945A (enExample) |
| ZA (1) | ZA763096B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU572815B2 (en) * | 1982-12-29 | 1988-05-19 | Armour Pharmaceutical Company | Pharmaceutical calcitonin compositions for intranasal application |
| JPS61267528A (ja) * | 1984-11-26 | 1986-11-27 | Yamanouchi Pharmaceut Co Ltd | 吸収促進剤を含有するカルシトニン経鼻剤 |
| HU198626B (en) * | 1986-05-27 | 1989-11-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient |
| HU205861B (en) * | 1986-12-19 | 1992-07-28 | Sandoz Ag | Process for producing hydrosole of pharmaceutically effective material |
| MY102411A (en) * | 1986-12-23 | 1992-06-17 | Ciba Geigy Ag | Nasal solutions |
| GB9120672D0 (en) * | 1991-09-28 | 1991-11-06 | Ciba Geigy Ag | Pharmaceutical compositions |
| IT1255895B (it) * | 1992-10-20 | 1995-11-17 | Laura Chiodini | Composizioni farmaceutiche contenenti una calcitonina |
| CA2321924A1 (en) * | 1998-02-25 | 1999-09-02 | Abbott Laboratories | Butorphanol sustained release formulations |
| EP4433028A1 (en) * | 2021-11-19 | 2024-09-25 | Nanoform Finland Oyj | A composition comprising nanosized active pharmaceutical ingredient |
-
1976
- 1976-05-21 CA CA253,137A patent/CA1098444A/en not_active Expired
- 1976-05-22 DE DE19762623074 patent/DE2623074A1/de not_active Withdrawn
- 1976-05-24 NL NL7605559A patent/NL7605559A/xx not_active Application Discontinuation
- 1976-05-24 FR FR7615645A patent/FR2312260A1/fr active Granted
- 1976-05-24 GB GB21405/76A patent/GB1548984A/en not_active Expired
- 1976-05-25 ZA ZA00763096A patent/ZA763096B/xx unknown
- 1976-05-25 BE BE167303A patent/BE842189A/xx not_active IP Right Cessation
- 1976-05-25 AU AU14252/76A patent/AU507537B2/en not_active Expired
- 1976-05-25 IE IE1101/76A patent/IE43770B1/en unknown
- 1976-05-25 NZ NZ180945A patent/NZ180945A/xx unknown
- 1976-05-25 IL IL49653A patent/IL49653A/xx unknown
- 1976-05-26 JP JP51060227A patent/JPS51144721A/ja active Pending
-
1982
- 1982-04-01 HK HK159/82A patent/HK15982A/xx unknown
- 1982-12-30 MY MY284/82A patent/MY8200284A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU507537B2 (en) | 1980-02-21 |
| MY8200284A (en) | 1982-12-31 |
| GB1548984A (en) | 1979-07-18 |
| NL7605559A (nl) | 1976-11-30 |
| CA1098444A (en) | 1981-03-31 |
| IL49653A0 (en) | 1976-07-30 |
| JPS51144721A (en) | 1976-12-13 |
| BE842189A (fr) | 1976-11-25 |
| DE2623074A1 (de) | 1976-12-09 |
| NZ180945A (en) | 1978-07-10 |
| FR2312260A1 (fr) | 1976-12-24 |
| IL49653A (en) | 1979-07-25 |
| HK15982A (en) | 1982-04-08 |
| AU1425276A (en) | 1977-12-01 |
| IE43770L (en) | 1976-11-26 |
| IE43770B1 (en) | 1981-05-20 |
| ZA763096B (en) | 1978-01-25 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |